British Journal of Anaesthesia, Vol 75, Issue 1 43-46, Copyright © 1995 by The Board of Management and Trustees of the British Journal of Anaesthesia
DJR. Duthie, P. S. Woolman and A. R. Doyle
In a randomized, controlled study of 24 patients undergoing myocardial
revascularization, we found that enoximone 0.5 mg kg-1 i.v., followed by 5
micrograms kg-1 min-1, when rewarming after hypothermic cardiopulmonary
bypass, prevented subsequent cooling of the periphery after transfer to the
intensive care unit. Skin surface temperatures on the foot increased by
mean 0.33 (SD 0.5) degree C h-1 in the enoximone group, but decreased by
0.43 (0.4) degree C h-1 in the control group until core temperature had
increased to 37 degrees C (P < 0.001); only then did peripheral
temperatures begin to increase in the control group. Enoximone did not
merely redistribute heat from the core to the periphery. The capacity to
transfer heat by the circulation rather than the ability to generate heat
in the core appeared to limit body warming in the ICU after hypothermic
cardiopulmonary bypass.
CLINICAL INVESTIGATIONS
Enoximone and warming after hypothermic cardiopulmonary bypass
Department of Anaesthesia, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE; Clinical Physics Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF
![]()
CiteULike
Connotea
Del.icio.us What's this?